AGENDA - Speakers & Sessions Subject to Change

Founded in 1863 by a group of concerned citizens to help preserve the nation, The Union League Club of New York has built, over ensuing years, a record of distinguished service to our country. Members of The Union League Club were instrumental in establishing The Metropolitan Museum of Art in 1870 as well as the Sanitary Commission, a predecessor organization to the American Red Cross. It helped erect the Statue of Liberty in New York Harbor and the Lincoln Monument in Union Square. Its members were instrumental in bringing down the "Boss" Tweed ring and in raising funds to outfit American soldiers in several conflicts.

Many prominent civic, state and national leaders have enjoyed the fellowship of the ULC. Theodore Roosevelt managed his early political career from the Club's chambers. J. Pierpont Morgan was a regular, along with John Jay, William Cullen Bryant, Chester A. Arthur, and Thomas Nast. Fifteen Presidents, seven Senators, many Congressmen, diplomats, cabinet members, and scores of CEOs of major corporations have been members of the Club during the past hundred and fifty years.

Greeting Remarks:
Mr. Ransel N. Potter,
Founder & Managing Partner,
C3 Summit International,
USA

Dr. Maliha Hashmi,
Prominent Health Leader,
One of Top Seven Female Health Leaders,
Mena Region,
Kingdom Of Saudi Arabia

Welcoming Remarks:
C3 Summit Chair:
Dr. Ghassan Abou-Alfa, MD,
MBA Attending Physician,
Memorial Sloan Kettering Cancer Center;
Chair,
Heatobiliary Task Force,
National Cancer Institute,
USA

Opening Remarks:
Building a Knowledge Economy

Mr. David Jackson,
Founder & Chairman,
Solitaire Partners,
USA

Chief Executive Officer,
Istithmar World,
2006-2010,
Dubai

Follow up Q&A:
10:10 am - 10:40 am

The 2021 C3 US-Arab Healthcare & Business Summit tackles the current state of the global healthcare sector and explores trends and issues impacting healthcare providers, governments, payers, patients, and other stakeholders. It also provides suggestions for them as they seek to redefine the healthcare ecosystem based on examples from the market.

Aging and growing populations, greater prevalence of chronic diseases, exponential advances in innovative, and costly, new digital technologies continue to increase healthcare demand and expenditures. Healthcare stakeholders, providers, governments, payers, consumers, and other companies/organizations”struggling to manage clinical, operational, and financial challenges-envision a future in which new business and care delivery models, aided by digital technologies, may help to solve today's problems and to build a sustainable foundation for affordable, accessible, high-quality healthcare. This vision may have a greater probability of becoming a reality if all stakeholders actively participate in shaping the future by way of shifting focus away from system of sick care in which we treat patients after they fall ill, to one of healthcare which supports well-being, prevention, and early intervention.

Simply stated, the 2021 C3 US-Arab Healthcare & Business Summit is about exploring ideas, suggestions, and realistic recommendations as possible solutions to today's bilateral security, technology, commercial development and healthcare challenges. Based on the insights of the Summit's global leaders and thinkers, on the importance of moving healthcare, commerce and philanthropy beyond bilateral borders, participants can begin to immediately implement what they will hear and learn to help bring these innovations, pilot projects, cases studies, public-private partnerships and other practical solutions to fruition in the global commercial and healthcare sectors.

Dr. Deborah L. Birx, MD is a world-renowned physician, scientist and expert on HIV/AIDS and infectious diseases and a diplomat who served as a special representative for global health diplomacy. Most recently, Dr. Birx served on the White House Coronavirus Task Force from Mar. 2020 to Jan. 2021. Her four-decade-long career has focused on HIV/AIDS, TB/HIV, immunology, vaccine research, global pandemics and global health. As the U.S. Global AIDS Coordinator for presidents Barack Obama and Donald Trump, Dr. Birx oversaw the implementation of the 6 B/yr U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nation to combat a single disease in history, as well as all U.S. government engagement with the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Serving as the U.S. Special Representative for Global Health Diplomacy, she aligned the U.S. Government's diplomacy with foreign assistance programs that address global health challenges and accelerate progress toward achieving an AIDS-free generation; ending preventable child and maternal deaths; and preventing, detecting, and responding to infectious disease threats.

In 1980, Dr. Birx began her career with the Department of Defense (DoD) first as a Medical Resident in Internal Medicine, Fellow in Clinical Immunology and then as a military-trained clinician in immunology, focusing on HIV/AIDS vaccine research. From 1985-1989 she served as an Assistant Chief of the Hospital Immunology Service at Walter Reed Army Medical Center. Through her professionalism and leadership in the field, she served as the Director of the U.S. Military HIV Research Program (USMHRP) at the Walter Reed Army Institute of Research from 1996-2005. Dr. Birx began and led one of the most influential HIV vaccine trials in history (known as RV 144, or the Thai trial), which provided the first supporting evidence of any vaccine's potential effectiveness in preventing HIV infection. During this time, she also rose to the rank of Colonel, bringing together the Navy, Army, and Air Force in a new model of cooperation - increasing the efficiency and effectiveness of the U.S. military's HIV/AIDS efforts through inter-and intra-agency collaboration. Then known as Colonel Birx, she was awarded two prestigious U.S. Meritorious Service Medals and the Legion of Merit Award for her groundbreaking research, leadership and management skills during her tenure at DoD.

From 2005-2014, Dr. Birx served as the Director of the Centers for Disease Control and Prevention's (CDC) Division of Global HIV/AIDS (DGHA) in the CDC Center for Global Health. As DGHA Director, she utilized her leadership ability, superior technical skills, and passion to achieve tremendous health impact. She successfully led the implementation of CDC's PEPFAR programs around the world and managed an annual budget of more than $1.5 billion. Dr. Birx was responsible for all of the agency's global HIV/AIDS activities, including providing oversight to more than 400 staff at headquarters, over 1,500 staff in the field, and more than 45 country and regional offices in Africa, Asia, the Caribbean, and Latin America. Recognized for her distinguished and dedicated commitment to building local capacity and strengthening quality laboratory health services and systems in Africa, in 2011, Dr. Birx received a Lifetime Achievement Award from the African Society for Laboratory Medicine. In 2014, CDC honored her leadership in advancing the agency's HIV/AIDS response with the highly prestigious William C. Watson, Jr. Medal of Excellence, the highest honor bestowed by the CDC.

Dr. Birx received her medical degree from the Hershey School of Medicine, Pennsylvania State University. She trained in internal medicine and basic and clinical immunology at the Walter Reed Army Medical Center and the National Institutes of Health. Dr. Birx is board certified in internal medicine, allergy and immunology, and diagnostic and clinical laboratory immunology. She has published over 240 manuscripts in peer-reviewed journals, authored nearly a dozen chapters in scientific publications, as well as developed and patented vaccines. She has received multiple awards for her work.

There has been plenty of press and opinions of the future of healthcare and the role wellness plays in creating this future. The numerous descriptions of things like Digital Twins, Blockchain, Telemedicine, and other emerging technologies can create anxiety among practitioners, researchers, administrators, and institutions that entered industry and community with a very traditional approach to assist patients, clients, and guests that now has to face digital transformation as part of their reality.

Join us for an exploration of our industry’s new reality that includes how you and our industry's people acknowledge and adapt to digital transformation, prepare for the sea change in value recognition, and position ourselves for success. Our healthcare/wellness industry is colliding with the world of technology, entertainment, and the built environment at a rapid pace. Our panel will provide insights into how best to position your role in the future of the healthcare and wellness industry.

Mr. Ransel N. Potter,
Founder & Managing Partner,
C3 Summit International,
USA

Mr. Mick Merritt,
Chief Operating Officer,
Penn Signature Services,
Penn Medicine,
USA

Ambassador Dr. Deborah L. Birx,
White House CoronavirusTask Force (retired),
USA

His Excellency Shaikh Abdulla R. Al Khalifa,
Ambassador of the Kingdom of Bahrain to the United States

As many believe, some of the best outcomes take place as a result of a bilateral relationship. For this reason, building a knowledge economy between regions continues to encourage multinational "partners" to seek bilateral cooperation creating a supporting "push and pull" dynamic of regional prosperity. It is shown that in knowledge-intensive countries, a knowledge economy acts as a mediating variable between a holistic view of the present and future.

C3 2021 Leadership Award Recipient:

HRH Prince Salman bin Hamad Al Khalifa
Crown Prince,
Deputy Supreme Commander
and
Prime Minister,
Kingdom of Bahrain

As an avenue to cementing bilateral relations, the C3 Leadership Award recognizes the importance of an individual's initiatives and interests based on “social and commercial diplomacy,” thereby making an invaluable, enduring contribution to both their country and global community.

With these personal achievements in mind, and a focus on increasing commercial ties between the US and the Arab world, from the personal interchange that it involves to the mutual economic interests that it develops, leadership is critical to encouraging dialogue and imagination, in order to explore new opportunities that will grow regional and global prosperity. The end result will pave the path to increased progress for economic engagement between all global markets.

The pandemic's disruptions to the healthcare industry were immediate and acute. While U.S. hospitals usually have plans for dealing with mass casualties and natural disasters, few had contemplated, much less planned for, the arrival of a global pandemic that was the biggest threat to American lives since the 1918 Spanish flu. One of the most immediate disruptions was the collapse of supply lines for personal protective equipment (PPE). The industry learned that it had “too significant a reliance on a supply chain based in just one part of the world, i.e. China. Another challenge was finding the space and beds to accommodate the influx of COVID-19 patients, but an even greater problem was staffing those beds. Also unexpected was the impact on America's healthcare workers and the amount of misinformation and conflicting messaging they were asked to address, which left people unsure of whom to listen to and how to protect themselves from the virus.

Finally, with all the unfortunate disruptions, there was the one most welcomed disruption: record setting vaccine discoveries and distributions to the global population. Also, the pandemic pushed healthcare systems into an arena previously occupied primarily by government and local health departments: public health. When healthcare systems provided drive-through testing facilities, created web-based symptom checkers or call centers so people could ask questions about the virus, launched vaccine clinics, or advised schools and businesses about how to safely reopen, they were providing public health services.

The most lasting new healthcare norm promoted by the global pandemic is likely to be telemedicine. Before the coronavirus, the public’s response to the idea of visiting a doctor via computer or cell phone was lukewarm at best, and neither Medicare nor private health insurance companies were interested in covering such visits. But when the pandemic hit, people adopted telehealth out of necessity. Same thing for providers. They needed to see their patients and telemedicine became the safest and the most efficient way to provide remote healthcare. As a result, the pandemic led the way for government and insurance companies to recognize and pay for telehealth for patients.

Health systems are still working on developing and adopting patient-centered care and personalized therapies that will be necessary to facilitate the widespread utilization of personalized medicine, which differs significantly from the one-size-fits-all approaches to health care that have dominated medicine for most of human history. Guided by this patient-centered care, physicians have begun to embrace a new way of treating cancer patients called personalized medicine. Also referred to as precision medicine, this evolving field involves the use of diagnostic tests to determine which personalized therapies will work best for each patient. By combining the data from those tests with an individual’s medical history, circumstances, and values, health care providers can develop targeted approaches to cancer prevention and treatments